First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015)

Radiotherapy and Oncology

Volumn 100, Issue 1, 2011, Pages 93-100

  Yarnold, John R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer; Hypofractionation; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RELAPSE; EDEMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RADIATION DOSE; RADIOTHERAPY HYPOFRACTIONATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TELANGIECTASIA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING;

EID: 80051793946     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.06.026     Document Type: Article

References (27)

1. H.D. Thames, S.M. Bentzen, I. Turesson, M. Overgaard, and W. van den Bogaert Time-dose factors in radiotherapy: a review of the human data Radiother Oncol 19 1990 219 235 (Pubitemid 20369216)
2. D.J. Brenner, A.A. Martinez, G.K. Edmundson, C. Mitchell, H.D. Thames, and E.P. Armour Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13 (Pubitemid 34041562)
3. L. Cohen Radiotherapy in breast cancer. I. The dose-time relationship theoretical considerations Br J Radiol 25 1952 636 642
4. B.G. Douglas Superfractionation: its rationale and anticipated benefits Int J Radiat Oncol Biol Phys 8 1982 1143 1153 (Pubitemid 12053189)
5. J.R. Owen, A. Ashton, and J.M. Bliss Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial Lancet Oncol 7 2006 467 471 (Pubitemid 43779171)
6. S.M. Bentzen, R.K. Agrawal, and E.G. Aird The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial Lancet Oncol 9 2008 331 341
7. S.M. Bentzen, R.K. Agrawal, and E.G. Aird The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial Lancet 371 2008 1098 1107
8. T.J. Whelan, J.P. Pignol, and M.N. Levine Long-term results of hypofractionated radiation therapy for breast cancer N Engl J Med 362 2010 513 520
9. B. Jones, R.G. Dale, C. Deehan, K.I. Hopkins, and D.A. Morgan The role of biologically effective dose (BED) in clinical oncology Clin Oncol 13 2001 71 81 (Pubitemid 32377501)
10. I. Turesson The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships Radiother Oncol 15 1989 217 226 (Pubitemid 19193913)
11. A. Courdi, C. Ortholan, and J.M. Hannoun-Levi Long-term results of hypofractionated radiotherapy and hormonal therapy without surgery for breast cancer in elderly patients Radiother Oncol 79 2006 156 161 (Pubitemid 43884946)
12. Y.M. Kirova, F. Campana, and A. Savignoni Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy Int J Radiat Oncol Biol Phys 75 2009 76 81
13. ICRU Prescribing, recording and reporting photon beam therapy 1993 International Commission on Radiation Units and Measurements (ICRU)
14. ICRU Prescribing, recording and reporting photon beam therapy 1999 International Commission on Radiation Units and Measurements (ICRU)
15. J.S. Haviland, A. Ashton, and B. Broad Evaluation of a method for grading late photographic change in breast appearance after radiotherapy for early breast cancer Clin Oncol (R Coll Radiol) 20 2008 497 501
16. National Cancer Institute. CTEP Cancer Therapy Evaluation Program. Common Toxicity Criteria (CTC) Version 2.0; 1999. < http://www.ctep.info.nih.gov/ protocolDevelopment/electronic-applications/docs/ctcv20-4-30-992.pdf >.
17. J. Yarnold, A. Ashton, and J. Bliss Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial Radiother Oncol 75 2005 9 17 (Pubitemid 40616788)
18. A.M. Kirby, P.M. Evans, E.M. Donovan, H.M. Convery, J.S. Haviland, and J.R. Yarnold Prone versus supine positioning for whole and partial-breast radiotherapy: a comparison of non-target tissue dosimetry Radiother Oncol 96 2010 178 184
19. A.M. Moody, W.P. Mayles, and J.M. Bliss The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity Radiother Oncol 33 1994 106 112
20. A.J. Neal, and J.R. Yarnold Estimating the volume of lung irradiated during tangential breast irradiation using the central lung distance Br J Radiol 68 1995 1004 1008
21. C. Vrieling, L. Collette, and A. Fourquet The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups Radiother Oncol 55 2000 219 232 (Pubitemid 30408368)
22. W. Dorr, and J.H. Hendry Consequential late effects in normal tissues Radiother Oncol 61 2001 223 231 (Pubitemid 33127227)
23. J. Yarnold, S.M. Bentzen, C. Coles, and J. Haviland Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities Int J Radiat Oncol Biol Phys 79 2011 1 9
24. S.P. Lee, M.Y. Leu, J.B. Smathers, W.H. McBride, R.G. Parker, and H.R. Withers Biologically effective dose distribution based on the linear quadratic model and its clinical relevance Int J Radiat Oncol Biol Phys 33 1995 375 389
25. E. Donovan, N. Bleakley, and E. Denholm Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy Radiother Oncol 82 2007 254 264 (Pubitemid 46341474)
26. X.S. Qi, J. White, and X.A. Li Is α/β for breast cancer really low? Radiother Oncol 2011 10.1016/j.radonc.2011.01.010
27. S. Martin, M. Mannino, and A. Rostom Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer Clin Oncol 20 2008 502 505